System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Odayme Quesada is an expert in Cardiology at Christ Hospital (United States, Cincinnati) (United States). As of October 2026, ScienceLeadR ranks Odayme Quesada in the top 1% of experts worldwide for INOCA. Odayme Quesada has authored 146 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 1 of them ongoing. SLR score: 815 (community average: 125). How the SLR is computed.

LeadR Profile

Odayme Quesada Christ Hospital (United States, Cincinnati) United States
815 ScienceLeadR Reputation 815

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Public Health - Hematology - Biostatistics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2016 - 2026
Source: PubMed

Christ Hospital (United States, Cincinnati)

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 146

Citations

Citations: 1 768 1st author: 45 Last author: 37 Unique author: 1

Main journals

J Am Coll Cardiol 28
Circulation 21
Eur Heart J 9
Catheter Cardiovasc Interv 7
Journal of the Society for Cardiovascular Angiography & Interventions 6

Best Journals

Circulation 17
Eur Heart J 7

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Empagliflozin Improves Angina and Endothelial Dysfunction Indices in Angina and No Obstructive Coronary Arteries (ANOCA).
PMID 42817877 — cytokines, cells, vascular cell adhesion molecule-1, research design, spasm, serum, heart failure, stress, physiological, blood pressure, arteries, oxidative stress, biomarkers, aftercare, vascular diseases, endothelial cells, therapeutics, thrombosis, apoptosis		Arterioscler Thromb Vasc Biol20260
Preconception cardiometabolic markers and odds of developing adverse pregnancy outcomes: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
PMID 42395078 — pregnancy, pregnancy outcome, public health, metabolic syndrome		Am J Prev Cardiol20261
Complex MINOCA With Myocardial Bridge, Vasospasm, and Microvascular Dysfunction in an HCM Patient.
PMID 42216946 — coronary angiography, research design, myocardial infarction, arteries		JACC Case Rep20260
Oxygenation-Sensitive Cardiovascular Magnetic Resonance Imaging to Identify Coronary Microvascular and Vasomotor Dysfunction in Angina and No Obstructive Coronary Artery Disease.
PMID 42045805 — coronary artery disease, respiration, magnetic resonance imaging, predictive value of tests, arteries, biomarkers, healthy volunteers, endothelium		Eur Heart J Cardiovasc Imaging20260
Enhancing Invasive Coronary Function Testing: Multivessel Assessment of Coronary Microvascular Dysfunction in Patients with Angina and No Obstructive Coronary Artery Disease (ANOCA).
PMID 41871679 — research design, coronary artery disease, arteries, cardiology, blood circulation		Am Heart J20260

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 4
Phase 2 1
Phase 3 1
Phase 4 1

By status:

Completed 3
Recruiting 2
Active not recruiting 1
Suspended 1

By type:

Interventional 4
Observational 3

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 4
multicentric5to9 0
multicentricup10 1

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy
NCT05180773 — sodium-glucose transport proteins, enzyme inhibitors, receptors, adrenergic, beta, adrenergic agents, angiotensin ii, receptors, angiotensin, angiotensin-converting enzyme inhibitors, heart failure, pharmaceutical preparations, bromocriptine, heart, rivaroxaban, adrenergic antagonists, peptidyl-dipeptidase a, recycling, tablets, breast feeding, receptors, adrenergic, neprilysin, receptors, mineralocorticoid, angiotensins, angiotensin receptor antagonists, enzymes, therapeutics, peripartum period, mineralocorticoids, mouth, mineralocorticoid receptor antagonists, postpartum period, cardiomyopathies, women		Phase 4Recruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS